Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Duke Heart Center, Duke University Medical Center, Durham, North Carolina.
Am J Cardiol. 2014 Mar 1;113(5):749-56. doi: 10.1016/j.amjcard.2013.11.023. Epub 2013 Dec 12.
Although cocaine ingestion may cause or contribute to myocardial infarction (MI), few contemporary data are available describing cocaine-associated MI. We describe the characteristics, management, and outcomes of patients with MI and recent cocaine use from the Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines (ACTION Registry-GWTG) program. The study population was 102,952 patients enrolled in the American College of Cardiology ACTION Registry-GWTG from July 2008 to March 31, 2010 from 460 sites across the United States. Cocaine exposure was defined as self-reported cocaine use within the last 72 hours or a positive urine test for cocaine. Demographics and medical history, presenting characteristics, treatments, and in-hospital outcomes were reported on a standard case record form. A total of 924 patients (0.9%) were cocaine positive. Compared with cocaine-negative patients, cocaine-positive patients were younger and predominantly men with fewer cardiovascular risk factors. There was a higher percentage of ST elevation myocardial infarction (STEMI) (46.3% vs 39.7%) and cardiogenic shock at presentation in the cocaine-positive group, but the percentage of multivessel coronary artery disease was lower (53.3% vs 64.5%). Beta blockers within 24 hours (85.8% vs 90.1%, p <0.0001) and drug-eluting stents (40.1% vs 68.8%, p <0.0001 in patients with non-STEMI; 27.6% vs 54.6%, p <0.0001 in patients with STEMI) were used less commonly in cocaine-positive patients. Multivariable-adjusted in-hospital mortality was similar between cocaine-positive and cocaine-negative patients (adjusted odds ratio 1.00, 95% confidence interval 0.69 to 1.44, p value = 0.98). In conclusion cocaine-positive patients with acute coronary syndrome are younger with fewer risk factors, multivessel coronary artery disease and lower drug-eluting stent and β-blocker usage. Cocaine use was not associated with in-hospital mortality.
尽管可卡因摄入可能导致或促成心肌梗死(MI),但目前可用的关于可卡因相关 MI 的数据很少。我们描述了从美国 460 个地点的美国心脏病学会 ACTION 注册-GWTG 计划中的急性冠状动脉治疗和干预结果网络登记处(ACTION Registry-GWTG)招募的 102952 例 MI 和近期可卡因使用患者的特征、治疗和结局。研究人群为 2008 年 7 月至 2010 年 3 月 31 日期间在美国各地 460 个地点参加美国心脏病学会 ACTION 注册-GWTG 的 102952 例患者。可卡因暴露的定义是在过去 72 小时内自我报告可卡因使用或可卡因尿液检测阳性。人口统计学和病史、表现特征、治疗和住院结局均在标准病例记录表上报告。共有 924 例(0.9%)患者可卡因阳性。与可卡因阴性患者相比,可卡因阳性患者年龄较小,主要为男性,心血管危险因素较少。可卡因阳性组的 ST 段抬高型心肌梗死(STEMI)(46.3% vs 39.7%)和心源性休克的比例较高,但多支血管冠状动脉疾病的比例较低(53.3% vs 64.5%)。24 小时内使用β受体阻滞剂(85.8% vs 90.1%,p<0.0001)和药物洗脱支架(非 STEMI 患者中 40.1% vs 68.8%,p<0.0001;STEMI 患者中 27.6% vs 54.6%,p<0.0001)在可卡因阳性患者中较少使用。多变量校正后的住院死亡率在可卡因阳性和可卡因阴性患者之间相似(校正比值比 1.00,95%置信区间 0.69 至 1.44,p 值=0.98)。总之,患有急性冠状动脉综合征的可卡因阳性患者年龄较小,危险因素较少,多支血管冠状动脉疾病和药物洗脱支架及β受体阻滞剂使用率较低。可卡因使用与住院死亡率无关。